September 18, 2026

Emergent BioSolutions Inc. (EBS) Stock Analysis: Unpacking a 56.7% Potential Upside

Emergent BioSolutions Inc. (NYSE: EBS), a prominent player in the healthcare sector, is capturing investor attention with its significant potential upside of 56.7%. Specializing in preparedness and response solutions for..

RxSight, Inc. (RXST) Stock Analysis: Evaluating the 46% Potential Upside in Medical Device Innovation

RxSight, Inc. (RXST), a pioneering player in the medical devices sector, offers investors a unique proposition with its innovative approach to cataract surgery solutions. Specializing in light adjustable intraocular lenses..

Stoke Therapeutics, Inc. (STOK) Investor Outlook: Exploring a 60.60% Potential Upside in Biotechnology

Stoke Therapeutics, Inc. (NASDAQ: STOK) is making waves in the biotechnology sector with its innovative approach to developing treatments for severe genetic diseases. Based in Bedford, Massachusetts, this U.S.-based company..

AbCellera Biologics Inc. (ABCL) Stock Analysis: A Biotech Gem with a 34% Upside Potential

AbCellera Biologics Inc. (NASDAQ: ABCL) continues to capture investor attention due to its promising potential in the biotechnology sector. Based in Vancouver, Canada, this innovative company is carving a niche..

Treace Medical Concepts, Inc. (TMCI) Stock Analysis: Unveiling a 21.41% Upside Potential

Investors with an eye on the healthcare sector, particularly those interested in medical devices, might find Treace Medical Concepts, Inc. (NASDAQ: TMCI) an intriguing prospect. This company, headquartered in Ponte..

Ginkgo Bioworks Holdings, Inc. (DNA) Stock Analysis: Navigating Challenges in the Biotech Sector

Ginkgo Bioworks Holdings, Inc. (NYSE: DNA) stands at the intersection of biotechnology and innovation, offering a robust platform for cell engineering. Despite its promising technological capabilities, investors face a complex..

Arvinas, Inc. (ARVN) Stock Analysis: Uncovering a Potential 67.61% Upside in the Biotech Sector

Arvinas, Inc. (NASDAQ: ARVN), a prominent player in the biotechnology industry, is drawing attention from investors due to its innovative approach to drug development and a compelling potential upside of..

Dianthus Therapeutics (DNTH) Stock Analysis: Exploring a 39% Potential Upside in the Biotech Sector

Dianthus Therapeutics, Inc. (NASDAQ: DNTH) has captured the spotlight in the biotechnology industry with its impressive growth trajectory and a compelling potential upside of 39.24%. As a clinical-stage biotech firm,..

Maze Therapeutics, Inc. (MAZE) Stock Analysis: A 166.83% Potential Upside in the Biotech Arena

Individual investors seeking to capitalize on the growth potential within the biotechnology sector may find Maze Therapeutics, Inc. (NASDAQ: MAZE) an intriguing opportunity. With a market capitalization of $1.3 billion,..

Taysha Gene Therapies, Inc. (TSHA) Stock Analysis: Exploring a Potential 151.94% Upside in the Biotech Sector

For investors with a keen interest in the burgeoning field of gene therapy, Taysha Gene Therapies, Inc. (NASDAQ: TSHA) offers a compelling opportunity. With a market capitalization of $1.68 billion..

Zevra Therapeutics, Inc. (ZVRA) Stock Analysis: A Biotech Gem with 111% Potential Upside

Zevra Therapeutics, Inc. (NASDAQ: ZVRA) has emerged as a compelling player in the healthcare sector, particularly within the biotechnology industry. The company, based in Boston, Massachusetts, is on a promising..

Precigen, Inc. (PGEN) Stock Analysis: A 84% Upside Potential Sparks Investor Interest

Investors looking for promising opportunities in the biotechnology sector may want to turn their attention to Precigen, Inc. (NASDAQ: PGEN), a company at the forefront of gene and cell therapy..

Bicycle Therapeutics (BCYC) Stock Analysis: Exploring a 158% Potential Upside in the Biotech Sector

Bicycle Therapeutics plc (NASDAQ: BCYC) stands out in the biotechnology sector with its innovative approach to addressing diseases underserved by current treatments. Based in Cambridge, United Kingdom, the company is..

Myriad Genetics, Inc. (MYGN) Stock Analysis: Navigating the Challenges in Diagnostics & Research

Myriad Genetics, Inc. (MYGN), a prominent player in the healthcare sector, particularly in diagnostics and research, is navigating a challenging financial landscape. With a market capitalization of approximately $395.99 million,..

Verastem, Inc. (VSTM) Stock Analysis: Unveiling a 94% Potential Upside in the Biotech Arena

Verastem, Inc. (NASDAQ: VSTM), a burgeoning name in the biotechnology sector, is capturing the attention of investors with its promising potential upside of 94.26%. Specializing in the development and commercialization..

Akebia Therapeutics, Inc. (AKBA) Stock Analysis: Exploring a 337% Potential Upside

Investors with an eye on the healthcare sector might find Akebia Therapeutics, Inc. (NASDAQ: AKBA) an intriguing prospect. Operating in the niche of drug manufacturing, particularly focusing on specialty and..

Inventiva S.A. (IVA): Analyst Ratings Signal a 297% Upside Potential for Biotech Innovator

Inventiva S.A. – American Depositary Shares (IVA) represents a compelling opportunity for investors seeking exposure to a high-risk, high-reward segment of the biotech industry. Specializing in developing novel oral small..

Keros Therapeutics, Inc. (KROS) Stock Analysis: A Biotech Gem with 74.59% Upside Potential

Keros Therapeutics, Inc. (NASDAQ: KROS), a pioneering name in the biotechnology sector, presents a compelling investment opportunity with a potential upside of 74.59%. As a clinical-stage biopharmaceutical company, Keros is..

Embecta Corp. (EMBC) Investor Outlook: Navigating Challenges with a Strategic Focus on Diabetes Solutions

Embecta Corp. (NASDAQ: EMBC), a noteworthy player in the healthcare sector, is navigating the medical instruments and supplies industry with a specialized focus on diabetes care. As a company with..

Personalis, Inc. (PSNL) Stock Analysis: A Bold Bet in Cancer Genomics with a 30% Revenue Surge

Personalis, Inc. (NASDAQ: PSNL), a prominent player in the healthcare sector specializing in diagnostics and research, is making waves with its innovative cancer genomic solutions. Headquartered in Fremont, California, the..

Search

Funds

September 18, 2026

Search

Funds

September 18, 2026

FTSE 100

Funds